Gail Boudreaux

President, Chief Executive Officer & Director, Elevance Health

Search every verified Gail Boudreaux interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. On Elevance Health's second quarter 2026 earnings call, Gail Boudreaux reported strong quarterly performance and raised the company's adjusted EPS guidance for 2026. She stated that the company is managing the business with discipline and accelerating targeted investments in medical cost management, member experience, provider connectivity, operating efficiency, and Carelon's integrated capabilities. Boudreaux expressed confidence in the path ahead and reiterated the company's commitment to creating long-term value for members, customers, partners, and shareholders. During the call, Boudreaux and other executives discussed the company's approach to the ACA marketplace for 2027, with Felicia Norwood stating that Elevance Health would maintain a consistent posture focused on sustainable margins through disciplined, market-specific pricing. Regarding Medicaid, Boudreaux noted that the business remains a scaled and important contributor to EPS growth over time, while the company continues to execute its capital management effectively.